The firm said at the JP Morgan Healthcare Conference that a pivotal Phase III study, testing daraxonrasib in RAS-mutant ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

Research suggests vitamin D supplements may help some people with prediabetes restore normal blood sugar levels when combined with healthy lifestyle changes.

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Former Sen. Ben Sasse, R-Neb., announced Tuesday that he has been diagnosed with "metastasized, stage-four pancreatic cancer," writing in an X post that the diagnosis is "a death sentence." "Last week ...

Former senator and University of Florida president Ben Sasse announced he has stage 4 metastatic pancreatic cancer. Sasse served as a U.S. senator for Nebraska before becoming the president of the ...

Republican politician Ben Sasse shared sad news on social media Tuesday: He's expecting to die soon from pancreatic cancer. Sasse, who served in the United States Senate representing Nebraska from ...

Sasse said he has stage 4 pancreatic cancer. Former Nebraska Sen. Ben Sasse shared on Tuesday that he has been diagnosed with advanced pancreatic cancer. "Last week I was diagnosed with metastasized, ...